2. Protein Tyrosine Kinase/RTK
  3. IGF-1R
  4. Xentuzumab

Xentuzumab  (Synonyms: 珍妥珠单抗; BI 836845; Anti-Human IGF1 and IGF2 Recombinant Antibody)

目录号: HY-P99274 纯度: 99.71%
COA

摩尔计算器

Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) 是重组的人源单克隆抗体，靶向 IGF 配体 IGF1 和 IGF2。Xentuzumab 抑制 IGF1 和 IGF2 的生长促进信号，抑制 AKT 的激活。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

CAS No. : 1417158-65-6

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥3500
In-stock
5 mg ￥9500
In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Customer Review

Xentuzumab 相关抗体

Top Publications Citing Use of Products

MCE 顾客使用本产品发表的 1 篇科研文献

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody; BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation[1].

同型

Human IgG1 lambda2
推荐同型对照抗体
IC50 & Target

IGF1, IGF2[1]
体外研究
(In Vitro)

Xentuzumab (0.01-1 mM; 96 h) inhibits IGF type 1 receptor signaling and (0.1 μM; 48 h) AKT serine/threonine kinase (AKT) phosphorylation in VCaP, DuCaP, and MDA PCa 2b cell in a dose-dependent manner[1].
Xentuzumab (0.01-1 mM; 5-10 d) losses of antiproliferative activity against PTEN-null LNCaP or PC-3 cells when PTEN knockdown[1].
Xentuzumab (1 μM; 24-72 h) arrests cell cycle at sub-G1 phase and induces apoptosis in VCaP cells[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Xentuzumab 相关抗体:

Western Blot Analysis[1]

Cell Line: Prostate cancer VCaP cells
Concentration: 0.1 μM
Incubation Time: 24 h and 48 h
Result: Increased in cleaved caspase 3/7 and PARP.
Decreased the level of phosphorylation of FoxO3a (S253)/FoxO1 (T24).

Cell Cycle Analysis[1]

Cell Line: Prostate cancer VCaP cells
Concentration: 1 μM
Incubation Time: 24 h, 48 h, and 72 h
Result: Increased in cleaved caspase 3/7 and induces cell apoptosis.
Increased the sub-G1 cell population.
体内研究
(In Vivo)

Xentuzumab (200 mg/kg i.p., once weekly for 10 weeks) in inhibits tumor growth in LuCaP 96CR patient-derived xenograft model in mice[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Fox Chase CB17 severe combined immunodeficiency (SCID; CB17/lcr-Prkdc scid/lcrlcoCrl) male mice with LuCaP 96CR cell (s.c.)[1]
Dosage: 200 mg/kg
Administration: Intraperitoneal injection; once weekly for 10 weeks; sacrificed 6 hours after the last dose
Result: Resulted in significant reductions in tumor volume.
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

珍妥珠单抗
运输条件

Shipping with dry ice.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • Human IgG1 lambda2
Biological Activity
  • Immobilized Human IGF-I Protein, His Tag can bind Xentuzumab. The EC50 for this effect is 9.81 ng/mL.
纯度 & 产品资料

纯度: 99.71%

COA (264 KB) SDS-PAGE (87 KB) SEC-HPLC (97 KB)

抗体抑制剂使用指南 (1152 KB)
参考文献

Xentuzumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Xentuzumab1417158-65-6BI 836845 Anti-Human IGF1 and IGF2 Recombinant Antibody珍妥珠单抗BI836845BI-836845IGF-1RInsulin-like growth factor-1 receptorVCaPDuCaPMDA PCa 2bPTEN-null LNCaPInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Xentuzumab
目录号：
HY-P99274
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z